Home > Market > Market Stats > Strides pharma science
  1. S&P BSE SENSEX
    53,134.35 0 (0%)
  1. NIFTY 50 D
    Delayed by 15 mins

    15,810.85 0 (0%)
  1. NIFTY BANK D
    Delayed by 15 mins

    33,815.9 0 (0%)
  1. S&P BSE MIDCAP
    21,959.55 0 (0%)

SRID.BO Strides Pharma Science - Share price

331.8 -3.5 (-1.04%) 05 JUL 2022 10:11:01
331.55 0 (0%) 05 Jul 2022 10:12:40
Add Stock to Portfolio / Watchlist on mint Genie + Add Stock
  1. Open price337.55
  2. Prev close335.3
  3. Day high338.95
  4. Day low329.05
  5. 52 week high817.45
  6. 52 week low263.45
  7. Bid quantity0.0
  8. Volume11796
  1. Open price337
  2. Prev close335.95
  3. Day high339.25
  4. Day low329
  5. 52 week high818
  6. 52 week low263.35
  7. Bid quantity
  8. Volume292652

Strides Pharma Science Financials

Standalone
Revenue
3,315.87
Total Revenue
3,315.87
Costof Revenue Total
1,518.72
Gross Profit
1,797.15
Selling/ General/ Admin Expenses Total
1,150.49
Depreciation/ Amortization
201.72
Interest Exp( Inc) Net- Operating Total
45.67
Unusual Expense( Income)
-11.05
Other Operating Expenses Total
12.15
Total Operating Expense
2,876.59
Operating Income
439.28
Interest Inc( Exp) Net- Non- Op Total
-1,451.29
Gain( Loss)on Saleof Assets
23.38
Other Net
-21.05
Net Income Before Taxes
275.44
Provisionfor Income Taxes
31.65
Net Income After Taxes
243.79
Minority Interest
10.71
Net Income Before Extra Items
254.5
Total Extraordinary Items
13.94
Net Income
268.44
Income Availableto Com Excl Extra Ord
254.5
Income Availableto Com Incl Extra Ord
268.44
Diluted Net Income
268.44
Diluted Weighted Average Shares
8.97
Diluted EPS Excluding Extra Ord Items
28.37
DPS- Common Stock Primary Issue
2.5
Diluted Normalized EPS
27.05
COMPANY INFORMATION
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on development and manufacture of IP-led niche and pharmaceutical products. It operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Industry Biotechnology & Drugs
ISIN INE939A01011
BSE code 532531
NSE code STAR
Executive Chairperson of the Board, Managing DirectorArun   Kumar
Chief Financial Officer, Executive DirectorBadree   Komandur
Chief Executive Officer, U.S. businessTerrance   Coughlin
Chief Executive Officer, Managing Director of Strides Pharma Global, SingaporeMohan   Kumar
Chief Operating OfficerChristoph   Funke
Chief Human Resource OfficerTanaya   Mishra
Chief Information OfficerAnjani   Kumar
Chief Scientific OfficerRaviraj   Pillai
Compliance Officer, Company SecretaryManjula   Ramamurthy
Chief Risk Officer, Group General CounselSormistha   Ghosh
NEWS - Strides pharma science
View More News
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout